A new Graph Gaussian embedding method for analyzing the effects of cognitive training.
Mengjia XuZhijiang WangHaifeng ZhangDimitrios PantazisHua-Li WangQuanzheng LiPublished in: PLoS computational biology (2020)
Identifying heterogeneous cognitive impairment markers at an early stage is vital for Alzheimer's disease diagnosis. However, due to complex and uncertain brain connectivity features in the cognitive domains, it remains challenging to quantify functional brain connectomic changes during non-pharmacological interventions for amnestic mild cognitive impairment (aMCI) patients. We present a quantitative method for functional brain network analysis of fMRI data based on the multi-graph unsupervised Gaussian embedding method (MG2G). This neural network-based model can effectively learn low-dimensional Gaussian distributions from the original high-dimensional sparse functional brain networks, quantify uncertainties in link prediction, and discover the intrinsic dimensionality of brain networks. Using the Wasserstein distance to measure probabilistic changes, we discovered that brain regions in the default mode network and somatosensory/somatomotor hand, fronto-parietal task control, memory retrieval, and visual and dorsal attention systems had relatively large variations during non-pharmacological training, which might provide distinct biomarkers for fine-grained monitoring of aMCI cognitive alteration. An important finding of our study is the ability of the new method to capture subtle changes for individual patients before and after short-term intervention. More broadly, the MG2G method can be used in studying multiple brain disorders and injuries, e.g., in Parkinson's disease or traumatic brain injury (TBI), and hence it will be useful to the wider neuroscience community.
Keyphrases
- resting state
- functional connectivity
- white matter
- mild cognitive impairment
- traumatic brain injury
- end stage renal disease
- neural network
- early stage
- newly diagnosed
- cognitive decline
- ejection fraction
- working memory
- cerebral ischemia
- chronic kidney disease
- randomized controlled trial
- healthcare
- machine learning
- prognostic factors
- multiple sclerosis
- spinal cord
- cognitive impairment
- lymph node
- mental health
- spinal cord injury
- squamous cell carcinoma
- peritoneal dialysis
- radiation therapy
- patient reported outcomes
- neoadjuvant chemotherapy
- subarachnoid hemorrhage